Cargando…
The Heightened Risk of Fatty Liver Disorders in the Time of COVID-19
Autores principales: | Stanfield, Dylan, Lucey, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mayo Foundation for Medical Education and Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580527/ https://www.ncbi.nlm.nih.gov/pubmed/33276827 http://dx.doi.org/10.1016/j.mayocp.2020.10.020 |
Ejemplares similares
-
Eczema and Risk of Cardiovascular Disease: Heightened Awareness Needed
por: Fujiyoshi, Akira
Publicado: (2019) -
Pandemic heightens the need to combat cardiovascular diseases
por: Regional Health– Europe, The Lancet
Publicado: (2021) -
Heightening the awareness of headache disorders
Publicado: (2004) -
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
por: Carnagarin, Revathy, et al.
Publicado: (2021) -
Pregnancy and the Opioid Crisis: Heightened Effects of COVID-19
por: White, Ashley, et al.
Publicado: (2022)